Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study - PubMed (original) (raw)
Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study
William Whang et al. J Am Coll Cardiol. 2009.
Abstract
Objectives: We assessed the association between depression and sudden cardiac death (SCD) and cardiac events among individuals without baseline coronary heart disease (CHD).
Background: Depression is a risk factor for cardiac events and mortality among those with CHD, possibly from arrhythmia.
Methods: We studied depressive symptoms and a proxy variable for clinical depression consisting of severe symptoms and/or antidepressant medication use and their relationship to cardiac events in the Nurses' Health Study. Questionnaires in 1992, 1996, and 2000 assessed symptoms with the Mental Health Index (MHI-5), and antidepressant use was assessed in 1996 and 2000. Primary end points included SCD, fatal CHD, and nonfatal myocardial infarction.
Results: Among 63,469 women without prior CHD/stroke in 1992, 7.9% had MHI-5 scores <53, previously found to predict clinical depression. Depressive symptoms were associated with CHD events, and the relationship was strongest for fatal CHD, where the association remained significant even after controlling for CHD risk factors (hazard ratio [HR]: 1.49; 95% confidence interval [CI]: 1.11 to 2.00 for MHI-5 score <53). In models from 1996 onward, our proxy variable for clinical depression was most associated with SCD in multivariable models (HR: 2.33, 95% CI: 1.47 to 3.70), and this risk was primarily due to a specific relationship between antidepressant use and SCD (HR: 3.34, 95% CI: 2.03 to 5.50).
Conclusions: In this cohort of women without baseline CHD, depressive symptoms were associated with fatal CHD, and a measure of clinical depression including antidepressant use was specifically associated with SCD. Although antidepressant use might be a marker of worse depression, its specific association with SCD merits further study.
Figures
Figure 1
Distribution of MHI-5 score among 63,469 women without prior coronary heart disease, stroke, or cancer in 1992.
Figure 2
Unadjusted Kaplan-Meier curves of time to first event for sudden cardiac death (A), fatal coronary heart disease (B), and non-fatal myocardial infarction (C), according to depression status as defined by MHI-5 score<53 or reported use of antidepressant medication at baseline starting in 1996. Curves are truncated at 42 months. P values for log rank test=0.02 for sudden cardiac death, 0.31 for fatal coronary heart disease, and 0.80 for non-fatal myocardial infarction.
Figure 3
Unadjusted Kaplan-Meier curves of time to sudden cardiac death stratified by MHI-5 score<53 and reported use of antidepressant medication at baseline starting in 1996. P value for log rank test across strata=0.01.
Comment in
- Do depression or antidepressants increase cardiovascular mortality? The absence of proof might be more important than the proof of absence.
Narayan SM, Stein MB. Narayan SM, et al. J Am Coll Cardiol. 2009 Mar 17;53(11):959-61. doi: 10.1016/j.jacc.2008.12.009. J Am Coll Cardiol. 2009. PMID: 19281926 No abstract available. - Treatment-resistant depression and sudden cardiac death.
Carney RM, Freedland KE. Carney RM, et al. J Am Coll Cardiol. 2009 Sep 1;54(10):958; author reply 958-9. doi: 10.1016/j.jacc.2009.03.081. J Am Coll Cardiol. 2009. PMID: 19712809 Free PMC article. No abstract available.
Similar articles
- Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women.
Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I. Albert CM, et al. Circulation. 2005 Feb 1;111(4):480-7. doi: 10.1161/01.CIR.0000153813.64165.5D. Circulation. 2005. PMID: 15687137 - Association of Dietary Magnesium Intake with Fatal Coronary Heart Disease and Sudden Cardiac Death.
Li J, Hovey KM, Andrews CA, Quddus A, Allison MA, Van Horn L, Martin LW, Salmoirago-Blotcher E, Song Y, Manson JE, Albert CM, Lu B, Eaton CB. Li J, et al. J Womens Health (Larchmt). 2020 Jan;29(1):7-12. doi: 10.1089/jwh.2019.7775. Epub 2019 Dec 12. J Womens Health (Larchmt). 2020. PMID: 31829773 Free PMC article. - Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease.
Albert CM, Oh K, Whang W, Manson JE, Chae CU, Stampfer MJ, Willett WC, Hu FB. Albert CM, et al. Circulation. 2005 Nov 22;112(21):3232-8. doi: 10.1161/CIRCULATIONAHA.105.572008. Circulation. 2005. PMID: 16301356 - Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Maradit-Kremers H, et al. Arthritis Rheum. 2005 Feb;52(2):402-11. doi: 10.1002/art.20853. Arthritis Rheum. 2005. PMID: 15693010 Review. - Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis.
Kanaya AM, Grady D, Barrett-Connor E. Kanaya AM, et al. Arch Intern Med. 2002 Aug 12-26;162(15):1737-45. doi: 10.1001/archinte.162.15.1737. Arch Intern Med. 2002. PMID: 12153377 Review.
Cited by
- The association between the fluoxetine use and the occurrence of coronary heart disease: a nationwide retrospective cohort study.
Li FL, Sheih YT, Lin MH, Chen YC, Wu WT, Lin TK, Chou YC, Sun CA. Li FL, et al. BMC Cardiovasc Disord. 2024 Nov 9;24(1):628. doi: 10.1186/s12872-024-04280-5. BMC Cardiovasc Disord. 2024. PMID: 39522052 Free PMC article. - Predictors of anxiety among women of reproductive age in Nepal: a comprehensive nationwide analysis.
Tohan MM, Saha BR, Moon MI, Howlader MH, Rahman MA. Tohan MM, et al. Soc Psychiatry Psychiatr Epidemiol. 2024 Nov 9. doi: 10.1007/s00127-024-02791-2. Online ahead of print. Soc Psychiatry Psychiatr Epidemiol. 2024. PMID: 39520535 - Associations between daytime napping, sleep duration, and depression and 15 cardiovascular diseases: a Mendelian randomization study.
Li Y, Garg PK, Wu J. Li Y, et al. Cardiovasc Diagn Ther. 2024 Oct 31;14(5):771-787. doi: 10.21037/cdt-24-313. Epub 2024 Oct 15. Cardiovasc Diagn Ther. 2024. PMID: 39513145 Free PMC article. - Traditional and Emerging Sex-Specific Risk Factors for Cardiovascular Disease in Women.
Mehta PK, Gaignard S, Schwartz A, Manson JE. Mehta PK, et al. Rev Cardiovasc Med. 2022 Aug 16;23(8):288. doi: 10.31083/j.rcm2308288. eCollection 2022 Aug. Rev Cardiovasc Med. 2022. PMID: 39076638 Free PMC article. Review. - Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery Disease.
Desai SR, Dhindsa DS, Ko YA, Sandesara PB, Mehta A, Liu C, Tahhan AS, Hayek SS, Ejaz K, Hooda A, Alkhoder A, Islam SJ, Rogers SC, Beshiri A, Murtagh G, Kim JH, Wilson P, Almuwaqqat Z, Sperling LS, Quyyumi AA. Desai SR, et al. Am J Cardiol. 2023 Sep 15;203:315-324. doi: 10.1016/j.amjcard.2023.06.115. Epub 2023 Jul 28. Am J Cardiol. 2023. PMID: 37517126 Free PMC article. Clinical Trial.
References
- Frasure-Smith N, Lespérance F. Recent evidence linking coronary heart disease and depression. Can J Psychiatry. 2006;51(12):730–737. - PubMed
- Empana JP, Jouven X, Lemaitre RN, Sotoodehnia N, Rea T, Raghunathan TE, Simon G, Siscovick DS. Clinical depression and risk of out-of-hospital cardiac arrest. Arch Intern Med. 2006;166:195–200. - PubMed
- Whang W, Albert CM, Sears SF, Jr, Lampert R, Conti JB, Wang PJ, Singh JP, Ruskin JN, Muller JE, Mittleman MA. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol. 2005;45:1090–1095. - PubMed
- Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, Czajkowski SM, O’Connor C, Stone PH, Freedland KE. Depression, heart rate variability, and acute myocardial infarction. Circulation. 2001;104:2024–2028. - PubMed
- Bush DE, Ziegelstein RC, Patel UV, Thombs BD, Ford DE, Fauerbach JA, McCann UD, Stewart KJ, Tsilidis KK, Patel AL, Feuerstein CJ, Bass EB. Post-myocardial Infarction Depression. Evidence Report/Technology Assessment No. 123. AHRQ Publication Number 05-E018-1. Rockville, MD: Agency for Healthcare Research and Quality; 2005. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- R01 HL034594-21/HL/NHLBI NIH HHS/United States
- R01 HL034594-22/HL/NHLBI NIH HHS/United States
- R01 HL034594-20/HL/NHLBI NIH HHS/United States
- CA 87969/CA/NCI NIH HHS/United States
- R01 HL034594-23A2/HL/NHLBI NIH HHS/United States
- L30 HL089973/HL/NHLBI NIH HHS/United States
- R01 HL034594-15/HL/NHLBI NIH HHS/United States
- R01 HL068070-04/HL/NHLBI NIH HHS/United States
- R01 HL034594-16/HL/NHLBI NIH HHS/United States
- R01 HL034594-19/HL/NHLBI NIH HHS/United States
- R01 HL034594-18S1/HL/NHLBI NIH HHS/United States
- R01 HL034594-17/HL/NHLBI NIH HHS/United States
- K08 HL003783/HL/NHLBI NIH HHS/United States
- HL 03783/HL/NHLBI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- R01 HL034594-18/HL/NHLBI NIH HHS/United States
- R01 HL034594/HL/NHLBI NIH HHS/United States
- L30 HL089973-01/HL/NHLBI NIH HHS/United States
- R01 HL068070/HL/NHLBI NIH HHS/United States
- HL 34594/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources